0.915
DSS Inc Borsa (DSS) Ultime notizie
why smtc stock attracts strong analyst attentionDouble Your Capital Alerts - Newser
Why DSS Inc. stock attracts strong analyst attentionWeekly Big Movers - Newser
How DSS Inc. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
What makes DSS Inc. stock price move sharplyMassive Upside Selection - Newser
DSS appoints HTL International as new auditor, replacing Grassi & Co. - Investing.com
DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger - GlobeNewswire
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth | DSS Stock News - GuruFocus
DSS reports Q1 EPS (55c) vs. (58c) last year - TipRanks
DSS, Inc. Reports Strong Q1 2025 Financial Results with 28% Revenue Growth and Significant Debt Reduction - Nasdaq
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth - GlobeNewswire
DSS Delivers Triple Win in Q1 2025: 28% Revenue Jump, $9.5M Asset Sale, and Major Debt Reduction - Stock Titan
The 7 Best Robinhood Stocks Under 2 Dollars To Buy For July 2025 - The Stock Dork
DSS, Inc. Interview To Air On Bloomberg U.S. On The RedChip Money Report® - Barchart.com
Market Watch Highlights: Impact BioMedical Inc (IBO) Ends on an Upturn Note at 0.61 - DWinneX
Daily Turnover | The turnover of Impact BioMedical on 5/2 was $144.03 Million, Ranking 625 - AInvest
Market Resilience: Impact BioMedical Inc (IBO) Finishes Weak at 0.50, Down -2.92 - DWinneX
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Recei - GuruFocus
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings - The Globe and Mail
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., - GlobeNewswire
Closing Figures: Impact BioMedical Inc (IBO)’s Positive Finish at 0.42, Up 1.11 - DWinneX
The VA EHR modernization roadmap under the Trump administration - Federal News Network
Insider Activity Roundup: Monday's Top Buys and Sells in US Stocks - Investing.com
DSS, Inc. sells $845,012 in Impact Biomedical stock By Investing.com - Investing.com Canada
DSS, Inc. sells $845,012 in Impact Biomedical stock - Investing.com
12 Industrials Stocks Moving In Friday's After-Market Session - Benzinga
DSS (NYSEAMERICAN:DSS) Share Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
12 Industrials Stocks Moving In Monday's Intraday Session - Benzinga
DSS Inc. (DSS) reports earnings - Quartz
DSS Inc. sells $1.95 million worth of Impact Biomedical shares By Investing.com - Investing.com Canada
DSS Inc. sells $1.95 million worth of Impact Biomedical shares - Investing.com Australia
Impact BioMedical Inc. (IBO) reports earnings - Quartz
DSS, Inc. sells $249,408 in Impact Biomedical stock By Investing.com - Investing.com UK
DSS, Inc. sells $249,408 in Impact Biomedical stock - Investing.com
12 Industrials Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
DSS announces sale of Celios to Impact BioMedical - MSN
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth - GlobeNewswire
Alset Inc. CEO Chan Heng Fai acquires $21,661 in common stock - MSN
DSS jumps on sale of Celios air purification business - MSN
Impact Biomedical Inc. Announces Acquisition of Celios®, 'Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality” - The Manila Times
Why is DSS offloading its innovative air purification tech? Inside the $1.15M strategic pivot - StockTitan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):